- Report
- January 2023
- 197 Pages
Global
From €4762EUR$5,130USD£3,950GBP
- Report
- April 2023
- 90 Pages
Global
From €3879EUR$4,038USD£3,330GBP
€4563EUR$4,750USD£3,918GBP
- Report
- April 2023
- 175 Pages
Global
€4607EUR$4,795USD£3,955GBP
- Report
- October 2023
- 188 Pages
Global
From €3414EUR$3,554USD£2,932GBP
€3794EUR$3,949USD£3,257GBP
- Report
- September 2023
- 236 Pages
Global
From €5716EUR$5,950USD£4,908GBP
- Report
- February 2023
- 168 Pages
Global
From €2402EUR$2,500USD£2,062GBP
- Report
- December 2023
- 194 Pages
Global
From €4755EUR$4,950USD£4,083GBP
- Report
- January 2023
- 232 Pages
Global
From €5284EUR$5,500USD£4,537GBP
- Report
- May 2023
- 250 Pages
Global
From €3074EUR$3,200USD£2,639GBP
€3843EUR$4,000USD£3,299GBP
- Report
- May 2023
- 250 Pages
Global
From €3074EUR$3,200USD£2,639GBP
€3843EUR$4,000USD£3,299GBP
- Report
- January 2023
- 187 Pages
Global
From €3043EUR$3,168USD£2,613GBP
€3458EUR$3,600USD£2,969GBP
- Report
- July 2020
- 416 Pages
Global
From €4669EUR$4,860USD£4,009GBP
- Report
- March 2022
- 120 Pages
Global
From €2402EUR$2,500USD£2,062GBP
- Report
- June 2021
- 120 Pages
Global
From €2402EUR$2,500USD£2,062GBP
- Report
- October 2021
- 103 Pages
United States
From €2642EUR$2,750USD£2,268GBP
€5284EUR$5,500USD£4,537GBP
- Report
- November 2020
- 76 Pages
Global
From €4755EUR$4,950USD£4,083GBP
- Report
- January 2021
- 21 Pages
Global
- Report
- May 2021
- 164 Pages
Global
From €3043EUR$3,168USD£2,613GBP
€3458EUR$3,600USD£2,969GBP
- Report
- November 2021
- 90 Pages
Global
From €4323EUR$4,500USD£3,712GBP
- Report
- April 2020
- 105 Pages
Europe
From €2017EUR$2,100USD£1,732GBP
€2882EUR$3,000USD£2,474GBP

The Biodefense market is a sector of the biotechnology industry that focuses on the development of products and services to protect against biological threats. This includes the development of vaccines, diagnostics, and treatments for infectious diseases, as well as the development of countermeasures to protect against bioterrorism. Biodefense products are designed to protect against a wide range of biological agents, including bacteria, viruses, and toxins.
The Biodefense market is driven by the need to protect against the increasing threat of biological agents, as well as the need to develop treatments for existing and emerging infectious diseases. Governments, healthcare organizations, and private companies are investing in the development of biodefense products and services.
Some of the major companies in the Biodefense market include Emergent BioSolutions, GlaxoSmithKline, Johnson & Johnson, Merck, Novavax, Pfizer, and Sanofi. These companies are developing a range of products and services to protect against biological threats, including vaccines, diagnostics, and treatments. Show Less Read more